Tang Kevin C's Form 4 filing
Aurinia Pharmaceuticals Inc. (AUPH) · filed Aug 5, 2025
- Accession no.
- 0001415889-25-021066
- Filed
- Aug 5, 2025
- Trade date
- Aug 1-5, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $13.6M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tang Kevin CCIK 0001178579 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | Common Shares | PPurchaseAcquired | +1,000,000 | $10.12 | +$10,120,000 | 11,029,500 | Indirect | |
| Aug 4, 2025 | Common Shares | PPurchaseAcquired | +100,000 | $11.34 | +$1,134,000 | 11,129,500 | Indirect | |
| Aug 5, 2025 | Common Shares | PPurchaseAcquired | +200,000 | $11.68 | +$2,336,000 | 11,329,500 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.